Compare

How Compliome compares.

Regulatory professionals weigh three alternatives: a generic AI chatbot, the free FDA websites, or a five-figure enterprise database. Here is where Compliome fits — and where it honestly doesn't.

Feature	Compliome	Generic AI(ChatGPT, Perplexity, NotebookLM)	Free FDA sources(eCFR, openFDA, ClinicalTrials.gov)	Enterprise reg-intel(legacy databases)
Purpose-built for FDA / 21 CFR		—
Cited answers traceable to the primary source		Web links it found	It is the source
Deterministic links to the exact CFR section / FDA PDF		—		Varies
Unified: regs + guidance + 510(k)/PMA + drugs + pharmacology + enforcement + trials + intl		—	Separate silos	Usually one slice
Interactive knowledge-graph visualization		—	—	—
Hybrid semantic + keyword retrieval over a curated corpus		Open web	—
Always-current automated ingestion (no manual uploads)		Web-dependent
Self-serve signup & transparent pricing				—
Affordable for individuals & small teams	$49–149/mo	$0–20/mo	Free	$10K–100K+/yr

Comparison reflects typical capabilities of each category as of 2026. Compliome is an informational research tool, not legal or regulatory advice.

vs. generic AI assistants

ChatGPT, Perplexity, and NotebookLM are capable generalists, but they have no curated FDA corpus. Citations are web links they happened to find — or only the documents you upload — and section text can be paraphrased or wrong. For compliance-critical work, an unverifiable citation is a liability. Compliome grounds every answer in the actual regulatory record and links to the exact source.

vs. free FDA sources

eCFR, openFDA, and ClinicalTrials.gov are authoritative — and they are exactly the data Compliome ingests. But they live in separate interfaces with no natural-language layer and no connections between them. Compliome unifies them, adds cited synthesis, and maps how a rule connects to guidance, devices, drugs, enforcement, and trials in one interactive graph.

vs. enterprise regulatory databases

The legacy platforms are powerful but priced for Big Pharma — five to six figures a year, gated behind sales calls and long procurement cycles, and none of them visualize the relationships between regulations. Compliome delivers cited, evidence-based research with an interactive graph at a transparent monthly price you can start today.

The difference

Cited answers and an interactive graph — in one place.

Plenty of tools now bolt an AI chatbot onto regulatory content. None of the affordable ones pair verifiable, primary-source citations with an interactive knowledge graph spanning 21 CFR, FDA guidance, device clearances, drug approvals, drug pharmacology, enforcement, clinical trials, and international sources. That combination is what makes Compliome different.

Start free trial

When Compliome isn't the right tool

You need a quality or document-management system. Compliome researches the public regulatory record; it doesn't replace a QMS or RIM platform. It works well alongside one.
You need legal or regulatory advice. Compliome provides cited, evidence-based information — not advice. For binding interpretation, consult qualified counsel or regulatory professionals.
You only ever read one CFR section at a time. If you never need synthesis, connections, or cross-domain context, the free eCFR website may be all you need.

See the difference for yourself.

14-day free trial with starter credits. Cancel anytime.

Start free trial View pricing